Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: Q4QHH3
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 12 | 14 | PF00675 | 0.254 |
CLV_NRD_NRD_1 | 56 | 58 | PF00675 | 0.291 |
CLV_PCSK_KEX2_1 | 12 | 14 | PF00082 | 0.254 |
CLV_PCSK_KEX2_1 | 56 | 58 | PF00082 | 0.291 |
CLV_PCSK_PC7_1 | 8 | 14 | PF00082 | 0.279 |
CLV_PCSK_SKI1_1 | 15 | 19 | PF00082 | 0.334 |
CLV_PCSK_SKI1_1 | 66 | 70 | PF00082 | 0.289 |
LIG_FHA_2 | 26 | 32 | PF00498 | 0.462 |
LIG_LIR_Nem_3 | 76 | 81 | PF02991 | 0.281 |
LIG_Pex14_2 | 74 | 78 | PF04695 | 0.366 |
LIG_SH3_3 | 52 | 58 | PF00018 | 0.403 |
MOD_GlcNHglycan | 2 | 5 | PF01048 | 0.291 |
MOD_N-GLC_2 | 5 | 7 | PF02516 | 0.254 |
MOD_NEK2_1 | 17 | 22 | PF00069 | 0.431 |
MOD_PIKK_1 | 17 | 23 | PF00454 | 0.454 |
MOD_SUMO_rev_2 | 14 | 20 | PF00179 | 0.511 |
TRG_ER_diArg_1 | 55 | 57 | PF00400 | 0.354 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HR95 | Leptomonas seymouri | 84% | 100% |
A0A0S4JSJ0 | Bodo saltans | 64% | 79% |
A0A1X0NRV9 | Trypanosomatidae | 68% | 78% |
A0A3S7WR26 | Leishmania donovani | 96% | 100% |
A4H625 | Leishmania braziliensis | 83% | 100% |
A4HUF3 | Leishmania infantum | 96% | 100% |
E9AN52 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 92% | 100% |